154 related articles for article (PubMed ID: 32028099)
1. Nanoimmunosensor based on atomic force spectroscopy to detect anti-myelin basic protein related to early-stage multiple sclerosis.
Garcia PS; Brum DG; Oliveira ON; Higa AM; Ierich JCM; Moraes AS; Shimizu FM; Okuda-Shinagawa NM; Peroni LA; da Gama PD; Machini MT; Leite FL
Ultramicroscopy; 2020 Apr; 211():112946. PubMed ID: 32028099
[TBL] [Abstract][Full Text] [Related]
2. An extensive search for autoantibodies to myelin basic protein in cerebrospinal fluid of non-multiple-sclerosis patients: implications for the pathogenesis of multiple sclerosis.
Warren KG; Catz I
Eur Neurol; 1999; 42(2):95-104. PubMed ID: 10473981
[TBL] [Abstract][Full Text] [Related]
3. Anti-MOG autoantibodies in Italian multiple sclerosis patients: specificity, sensitivity and clinical association.
Mantegazza R; Cristaldini P; Bernasconi P; Baggi F; Pedotti R; Piccini I; Mascoli N; La Mantia L; Antozzi C; Simoncini O; Cornelio F; Milanese C
Int Immunol; 2004 Apr; 16(4):559-65. PubMed ID: 15039386
[TBL] [Abstract][Full Text] [Related]
4. Relative frequency of autoantibodies to myelin basic protein and proteolipid protein in optic neuritis and multiple sclerosis cerebrospinal fluid.
Warren KG; Catz I
J Neurol Sci; 1994 Jan; 121(1):66-73. PubMed ID: 7510787
[TBL] [Abstract][Full Text] [Related]
5. Recognition and degradation of myelin basic protein peptides by serum autoantibodies: novel biomarker for multiple sclerosis.
Belogurov AA; Kurkova IN; Friboulet A; Thomas D; Misikov VK; Zakharova MY; Suchkov SV; Kotov SV; Alehin AI; Avalle B; Souslova EA; Morse HC; Gabibov AG; Ponomarenko NA
J Immunol; 2008 Jan; 180(2):1258-67. PubMed ID: 18178866
[TBL] [Abstract][Full Text] [Related]
6. A myelin basic protein antibody cascade in purified IgG from cerebrospinal fluid of multiple sclerosis patients.
Warren KG; Catz I
J Neurol Sci; 1990 Apr; 96(1):19-27. PubMed ID: 1693669
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous quantification of Myelin Basic Protein and Tau proteins in cerebrospinal fluid and serum of Multiple Sclerosis patients using nanoimmunosensor.
Derkus B; Acar Bozkurt P; Tulu M; Emregul KC; Yucesan C; Emregul E
Biosens Bioelectron; 2017 Mar; 89(Pt 2):781-788. PubMed ID: 27816592
[TBL] [Abstract][Full Text] [Related]
8. Serum autoantibodies to myelin peptides distinguish acute disseminated encephalomyelitis from relapsing-remitting multiple sclerosis.
Van Haren K; Tomooka BH; Kidd BA; Banwell B; Bar-Or A; Chitnis T; Tenembaum SN; Pohl D; Rostasy K; Dale RC; O'Connor KC; Hafler DA; Steinman L; Robinson WH
Mult Scler; 2013 Nov; 19(13):1726-33. PubMed ID: 23612879
[TBL] [Abstract][Full Text] [Related]
9. Intrathecal synthesis of autoantibodies to myelin basic protein in multiple sclerosis.
Catz I; Warren KG
Can J Neurol Sci; 1986 Feb; 13(1):21-4. PubMed ID: 2420428
[TBL] [Abstract][Full Text] [Related]
10. Recombinant forms of myelin antigens expressed on Chinese hamster ovary (CHO) cells as a tool for identification of autoantibodies in serum of multiple sclerosis patients.
Jaśkiewicz E; Michałowska-Wender G; Pyszczek A; Wender M
Folia Neuropathol; 2010; 48(1):45-8. PubMed ID: 20383810
[TBL] [Abstract][Full Text] [Related]
11. Neutralization of anti-myelin basic protein by cerebrospinal fluid of multiple sclerosis patients in clinical remission.
Warren KG; Catz I
J Neurol Sci; 1988 Dec; 88(1-3):185-94. PubMed ID: 2465390
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid anti-myelin antibodies are related to magnetic resonance measures of disease activity in multiple sclerosis.
Vogt MH; Teunissen CE; Iacobaeus E; Heijnen DA; Breij EC; Olsson T; Brundin L; Killestein J; Dijkstra CD
J Neurol Neurosurg Psychiatry; 2009 Oct; 80(10):1110-5. PubMed ID: 18931010
[TBL] [Abstract][Full Text] [Related]
13. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study.
Reindl M; Linington C; Brehm U; Egg R; Dilitz E; Deisenhammer F; Poewe W; Berger T
Brain; 1999 Nov; 122 ( Pt 11)():2047-56. PubMed ID: 10545390
[TBL] [Abstract][Full Text] [Related]
14. Kinetic profiles of cerebrospinal fluid anti-MBP in response to intravenous MBP synthetic peptide DENP(85)VVHFFKNIVTP(96)RT in multiple sclerosis patients.
Warren KG; Catz I
Mult Scler; 2000 Oct; 6(5):300-11. PubMed ID: 11064438
[TBL] [Abstract][Full Text] [Related]
15. Myelin Basic Protein-Induced Production of Tumor Necrosis Factor-α and Interleukin-6, and Presentation of the Immunodominant Peptide MBP85-99 by B Cells from Patients with Relapsing-Remitting Multiple Sclerosis.
Nielsen CH; Börnsen L; Sellebjerg F; Brimnes MK
PLoS One; 2016; 11(1):e0146971. PubMed ID: 26756931
[TBL] [Abstract][Full Text] [Related]
16. Myelin basic protein-reactive autoantibodies in the serum and cerebrospinal fluid of multiple sclerosis patients are characterized by low-affinity interactions.
O'Connor KC; Chitnis T; Griffin DE; Piyasirisilp S; Bar-Or A; Khoury S; Wucherpfennig KW; Hafler DA
J Neuroimmunol; 2003 Mar; 136(1-2):140-8. PubMed ID: 12620653
[TBL] [Abstract][Full Text] [Related]
17. High levels of cerebrospinal fluid IgM binding to myelin basic protein are associated with early benign course in multiple sclerosis.
Annunziata P; Pluchino S; Martino T; Guazzi G
J Neuroimmunol; 1997 Jul; 77(1):128-33. PubMed ID: 9209277
[TBL] [Abstract][Full Text] [Related]
18. Sulfatide isoform pattern in cerebrospinal fluid discriminates progressive MS from relapsing-remitting MS.
Novakova L; Singh AK; Axelsson M; Ståhlman M; Adiels M; Malmeström C; Zetterberg H; Borén J; Lycke J; Cardell SL; Blomqvist M
J Neurochem; 2018 Aug; 146(3):322-332. PubMed ID: 29676479
[TBL] [Abstract][Full Text] [Related]
19. Cross-reactivity between myelin oligodendrocyte glycoprotein and human endogenous retrovirus W protein: nanotechnological evidence for the potential trigger of multiple sclerosis.
de Luca V; Martins Higa A; Malta Romano C; Pimenta Mambrini G; Peroni LA; Trivinho-Strixino F; Lima Leite F
Micron; 2019 May; 120():66-73. PubMed ID: 30802755
[TBL] [Abstract][Full Text] [Related]
20. A highly specific and sensitive nanoimmunosensor for the diagnosis of neuromyelitis optica spectrum disorders.
de Souza Moraes A; Brum DG; Ierich JCM; Higa AM; Assis ASJ; Miyazaki CM; Shimizu FM; Peroni LA; Machini MT; Barreira AA; Ferreira M; Oliveira ON; Leite FL
Sci Rep; 2019 Nov; 9(1):16136. PubMed ID: 31695085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]